Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin

Photochemical and Photobiological Sciences

Volumn 6, Issue 12, 2007, Pages 1325-1331

  De Bruijn, Henriëtte S ^a   De Haas, Ellen R M ^a   Hebeda, Konnie M ^b   Van Der Ploeg Van Den Heuvel, Angélique ^a   Sterenborg, Henricus J C M ^a   Neumann, H A Martino ^a   Robinson, Dominic J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLEACHING; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLUORESCENCE; FRACTIONATION; ILLUMINATION; LIGHT INTENSITY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN;

EID: 36549022166     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b708340h     Document Type: Conference Paper

References (37)

1. J. C. Kennedy R. H. Pottier D. C. Pross Photodynamic Therapy with endogeneous protoporphyrin IX, basic principles and present clinical experience J. Photochem. Photobiol., B 1990 6 143 148
2. C. A. Morton S. B. Brown S. Collins S. Ibbotson H. Jenkinson H. Kurwa K. Langmack K. McKenna H. Moseley A. D. Pearse M. Stringer D. K. Taylor G. Wong L. E. Rhodes Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group Br. J. Dermatol. 2002 146 552 567
3. C. J. Kelty R. Ackroyd N. J. Brown T. J. Stephenson C. J. Stoddard M. W. Reed Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation Aliment. Pharmacol. Ther. 2004 20 1289 1296
4. A. Bogaards A. Varma K. Zhang D. Zack S. K. Bisland E. H. Moriyama L. Lilge P. J. Muller B. C. Wilson Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development Photochem. Photobiol. Sci. 2005 4 438 442
5. W. M. Star A. J. van't Veen D. J. Robinson K. Munte E. R. M. de Haas H. J. C. M. Sterenborg Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two hour interval: long-term follow-up Acta Dermatol. Venereol. 2006 86 412 417
6. E. R. M. de Haas B. Kruijt H. J. C. M. Sterenborg H. A. M. Neumann D. J. Robinson Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy J. Invest. Dermatol. 2006 126 2679 2686
7. N. van der Veen H. L. L. M. van Leengoed W. M. Star In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations Br. J. Cancer 1994 70 867 872
8. N. van der Veen K. M. Hebeda H. S. de Bruijn W. M. Star Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination Photochem. Photobiol. 1999 70 921 929
9. H. S. de Bruijn N. van der Veen D. J. Robinson W. M. Star Improvement of systemic 5-aminolevulinic acid photodynamic therapy in vivo using light fractionation with a 75-minute interval Cancer Res. 1999 59 901 904
10. D. J. Robinson H. S. de Bruijn J. de Wolf H. J. C. M. Sterenborg W. M. Star Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect Photochem. Photobiol. 2000 72 794 802
11. D. J. Robinson H. S. de Bruijn W. M. Star H. J. C. M. Sterenborg Dose and timing of the first light fraction in two fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin Photochem. Photobiol. 2003 77 319 323
12. H. S. de Bruijn A. van der Ploeg - van den Heuvel H. J. C. M. Sterenborg D. J. Robinson Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice; the influence of the dark interval J. Photochem. Photobiol., B 2006 85 184 190
13. A. Casas H. Fukuda G. Di, Venosa A. M. Battle The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization Br. J. Dermatol. 2000 143 564 572
14. R. F. Lopez M. V. Bentley M. Begona, Delgado-Charro R. H. Guy Optimization of aminolevulinic acid delivery by iontophoresis J. Control Release 2003 88 65 70
15. K. Choudry R. C. Brooke W. Farrar L. E. Rhodes The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy Br. J. Dermatol. 2003 149 124 130
16. A. Curnow B. W. McIlroy M. J. Postle-Hacon J. B. Porter A. J. MacRobert S. G. Bown Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridione iron chelating agents Br. J. Cancer 1998 78 1278 1282
17. A. Curnow A. J. MacRobert S. G. Bown Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid Lasers Surg. Med. 2006 38 325 331
18. J. Kloek G. Beijersbergen, van Hennegouwen Prodrugs of 5-aminolevulinic acid for photodynamic therapy Photochem. Photobiol. 1996 64 994 1000
19. A. Casas A. Battle Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy Curr. Med. Anticancer Agents 2002 2 465 475
20. N. Fortinos M. A. Campo F. Popowycz R. Gurny N. Lange 5-Aminolevulinic acid derivatives in photomedicine: basics, application and perspectives Photochem. Photobiol. 2006 82 994 1015
21. S. Battah S. O'Neill C. Edwards S. Balaratnam P. Dobbin A. J. MacRobert Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study Int. J. Biochem. Cell Biol. 2006 38 1382 92
22. M. Tarstedt I. Rosdahl B. Berne K. Svanberg A. M. Wennberg A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp Acta Dermatol. Venereol. 2005 85 424 428
23. J. M. Gaullier K. Berg Q. Peng H. Anholt P. K. Selbo L. W. Ma J. Moan Use of 5-aminolevulinic acid esteres to improve photodynamic therapy on cells in culture Cancer Res. 1997 157 1481 1486
24. A. Casas H. Fuduka G. Di, Venosa A. Batlle Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy Br. J. Cancer 2001 85 279 284
25. J. Moan L. W. Ma A. Juzeniene V. Iani P. Jezunas F. Apricena Q. Peng Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters Int. J. Cancer 2003 103 132 135
26. S. R. Wiegell H. C. Wulf Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate J. Am. Acad. Dermatol. 2006 54 647 651
27. D. I. Kuijpers M. R. Thissen C. A. Thissen M. H. Neumann Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma J. Drug Dermatol. 2006 5 642 645
28. P. Juzenas S. Sharfaei J. Moan R. Bissonnette Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester J. Photochem. Photobiol., B 2002 67 11 17
29. D. J. Robinson H. S. de Bruijn N. van der Veen M. R. Stringer S. B. Brown W. M. Star Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect Photochem. Photobiol. 1998 67 140 149
30. J. Moan L. W. Ma V. Iani A. Juzeniene Influence of light exposure on the kinetics of protoporphyrin IX formation in normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester J. Invest. Dermatol. 2005 125 1039 1044
31. H. S. de Bruijn W. Sluiter A. van der Ploeg - van den Heuvel H. J. C. M. Sterenborg D. J. Robinson Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy Photodermatol. Photoimmunol. Photomed. 2006 22 238 246
32. I. A. Boere D. J. Robinson H. S. de Bruijn J. van den Boogert H. W. Tilanus H. J. Sterenborg R. W. de Bruin Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy Photochem. Photobiol. 2003 78 271 277
33. D. J. Robinson H. S. de Bruijn N. van der Veen M. R. Stringer S. B. Brown W. M. Star Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumours in hairless mouse skin Photochem. Photobiol. 1999 69 61 70
34. I. A. Boere D. J. Robinson H. S. de Bruijn J. Kluin H. W. Tilanus H. J. Sterenborg R. W. de Bruin Protoporphyrin IX fluorescence photobleaching and the response of rat barret's esophagus following 5-aminolevulinic acid photodynamic therapy Photochem. Photobiol. 2006 82 1638 1644
35. M. J. Niedre C. S. Yu M. S. Patterson B. C. Wilson Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid Br. J. Cancer 2005 92 298 304
36. E. Rud O. Gederaas A. Høgset K. Berg 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters Photochem. Photobiol. 2000 71 640 647
37. N. van der Veen H. S. de Bruijn R. J. Berg W. M. Star Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice Br. J. Cancer 1996 73 925 930